Akums Drugs & Pharmaceuticals Strong Q3 FY26 Performance Driven by CDMO Volume Growth and Margin Expansion
Akums Drugs & Pharmaceuticals reported a strong performance for Q3 FY26, with operating revenue reaching INR1,160 crores, marking a 14.8%…